Document Detail

Essential role of citrate export from mitochondria at early differentiation stage of 3T3-L1 cells for their effective differentiation into fat cells, as revealed by studies using specific inhibitors of mitochondrial di- and tricarboxylate carriers.
MedLine Citation:
PMID:  15862280     Owner:  NLM     Status:  MEDLINE    
1,2,3-Benzenetricarboxylate (BTA) and n-butylmalonate (BM), specific inhibitors of the mitochondrial tricarboxylate and dicarboxylate carrier, respectively, have been used to study the contribution of citrate export from mitochondria to the accumulation of fat in 3T3-L1 cells. Continuous treatment of the cells with BTA or BM for 5 days after the induction of differentiation caused a significant reduction in fat accumulation in the cells in an inhibitor concentration-dependent manner. These inhibitory effects of BTA and BM were not due to their side effects on DNA replication, since similar inhibition of fat accumulation was not observed with ordinary inhibitors of DNA replication. A similar reduction in fat accumulation was also observed when the cells were treated with BTA or BM for only 2 days just after induction of differentiation. However, interestingly, treatment of the cells with an inhibitor starting 2 days after the induction did not result in reduced fat accumulation. Furthermore, Northern analysis clearly indicated that transcript levels of peroxisome proliferator-activated receptor gamma (PPARgamma) and adipose-type fatty acid binding protein (A-FABP) were well correlated with the levels of fat accumulation. These results clearly indicate the essential role of citrate export from the mitochondrial matrix to the cytosol at the early differentiation stage of 3T3-L1 cells for their effective differentiation into fat cells.
Kazuaki Kajimoto; Hiroshi Terada; Yoshinobu Baba; Yasuo Shinohara
Publication Detail:
Type:  Journal Article     Date:  2005-03-02
Journal Detail:
Title:  Molecular genetics and metabolism     Volume:  85     ISSN:  1096-7192     ISO Abbreviation:  Mol. Genet. Metab.     Publication Date:  2005 May 
Date Detail:
Created Date:  2005-05-02     Completed Date:  2005-09-26     Revised Date:  2005-11-17    
Medline Journal Info:
Nlm Unique ID:  9805456     Medline TA:  Mol Genet Metab     Country:  United States    
Other Details:
Languages:  eng     Pagination:  46-53     Citation Subset:  IM    
Institute for Genome Research, University of Tokushima, Kuramotocho-3, Tokushima 770-8503, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
3T3 Cells
Adipocytes / cytology*,  metabolism
Cell Differentiation / drug effects,  physiology*
Citric Acid / metabolism*
Citric Acid Cycle
Dicarboxylic Acids / pharmacology*
Lipid Metabolism
Lipids / antagonists & inhibitors
Mitochondria / drug effects,  metabolism*
Models, Biological
Tricarboxylic Acids / pharmacology*
Reg. No./Substance:
0/Dicarboxylic Acids; 0/Lipids; 0/Tricarboxylic Acids; 77-92-9/Citric Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Increased susceptibility of spinal muscular atrophy fibroblasts to camptothecin-induced cell death.
Next Document:  Calpain inhibition and insulin action in cultured human muscle cells.